REPORT: Pfizer and Allergan are considering making Brent Saunders CEO
Advertisement
Brendan McDermid/Reuters
Saunders is currently CEO of Allergan, which Pfizer is in talks to acquire. A deal, which could be the largest of 2015, may be reached by Thanksgiving, Bloomberg says, citing unidentified sources.
Advertisement
The 45-year-old Saunders was CEO of Allergan when it was acquired by Actavis. He took over the combined company, which was named Allergan Plc in March.
If all goes according to these plans, Saunders would take on the role instead of 62-year-0ld Pfizer CEO Ian Read, who has been in that position since 2010, Bloomberg said.
The full Bloomberg report, by Matthew Campbell, Ruth David and Cynthia Koons, is here.
Pfizer declined to comment. We've reached out to Allergan, and we'll update if we hear back.
Advertisement
- I got a $40K raise using this 30-second strategy. It made me realize loud work, not hard work, always wins.
- A millennial manager went viral after her Gen Z assistant picked up a work call while at the hair salon: 'Go off queen'
- Qatar Airways' new CEO explains why it's sticking with the Airbus A380 as other airlines retire the costly superjumbo
- Kia India looks to expand sales, service network to 700 touchpoints by year-end
- Shapoorji Pallonji’s Afcons Infra files DRHP for ₹7,000 crore IPO
- Water crisis affects businesses across Bengaluru; Is there room for cautious optimism?
- BenQ Zowie EC2-CW review – Premium wireless mouse for gamers
- Banks' GNPAs set to improve further to 2.1 pc by FY25: Care Ratings